Management of Facial Hyperpigmentation in Men

First-Line Treatment Algorithm

The American Academy of Dermatology recommends starting with triple combination therapy containing hydroquinone 2-4%, tretinoin 0.05-0.1%, and a topical corticosteroid, combined with mandatory daily broad-spectrum SPF 50+ sunscreen reapplied every 2-3 hours during sun.Ptr sun exposure 1
Apply triple combination formulation (hydroquinone + tretinoin + corticosteroid) as the most effective initial regimen for facial hyperpigmentation in men 1
Azelaic acid 15-20% serves as an effective alternative or adjunct, particularly beneficial for darker skin types due to lower irritation potential compared to hydroquinone 1

Apply broad-spectrum sunscreen SPF 50+ daily and reapply every 2-3 hours during sun exposure—this is non-negotiable and foundational to any hyperpigmentation treatment 2, 1
Wear wide-brimmed hats and UV-protective clothing during peak sun hours (10 AM-4 PM) 2

Add oral tranexamic acid 250 mg twice daily for persistent or refractory hyperpigmentation, which increases total efficacy to 90.48% compared to 73.68% with topical therapy alone, with lower recurrence rates 2, 1
Combining topical/intradermal tranexamic acid with oral tranexamic acid provides superior outcomes 2
Topical tranexamic acid can be added to the regimen but must be combined with rigorous sun protection 2
Topical niacinamide may provide additional benefit as an adjunct 1

Intradermal platelet-rich plasma (PRP) injections demonstrate superior efficacy with 53.66% mMASI reduction, representing the most effective treatment when topical therapy fails 2, 1
PRP combined with oral tranexamic acid shows higher efficacy with lower recurrence rates 1
Microneedling may be more effective than intradermal PRP for delivering treatments to hyperpigmented skin 1

Measure treatment efficacy using the Melasma Area and Severity Index (MASI) or modified MASI (mMASI) to objectively track improvement 1
Document baseline with serial photographs and monitor every 2-3 months 1
Hyperpigmentation is a chronic condition requiring maintenance therapy—expect to continue treatment for months and consider maintenance every 6 months 2, 1
Do not discontinue treatment prematurely as recurrence is common 2
Counsel patients to avoid smoking as this impairs treatment outcomes 1

Never use topical treatments without concurrent rigorous sun protection—treatment will fail without SPF 50+ reapplied every 2-3 hours 2
Do not use clascoterone for hyperpigmentation—it is only indicated for acne vulgaris and has no role in treating melanocyte dysfunction 1
Avoid prolonged topical corticosteroid use beyond 2 months due to skin atrophy risk 1
Do not apply photodynamic therapy (PDT) for hyperpigmentation—the evidence relates to actinic keratoses and photoaging, not primary hyperpigmentation disorders 3, 4
Recognize that genetic and hormonal factors may limit treatment success, requiring realistic patient expectations 1